MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..7 of 7 - per page
Order by
Multi-particles for oral formulations, based on coating technology with fluid bed or perforated coating pan. More
The present invention relates to a controlled release drug delivery system comprising a drug which is susceptible to enzymatic degradation by enzymes present in the intestinal tract; and a polymeric matrix which undergoes erosion in the... More
Biodegradable microbead or microparticle useful for the sustained localized delivery of biologically active proteins or other molecules of pharmaceutical interest More
A general formulation for safe oral sustained-release administration of amoxicillin and other beta-lactam antibiotics. It is predicted that the dosing can be decreased from four times a day to only one daily dose. Keywords: controlled release,... More
Rubicon has developed a Controlled Release Tablet of Vitamin C using its patented technology that ensures steady release of Vitamin C over 12 hours. The flavored coating provides a pleasant swallowing experience. More
Medium sized Indian company owns the patent for the preparation of sustained release Trimetazidine Dihydrochloride composition indicated for the treatment of angina and is now looking for out-licensing partners. More
Displaying 1..7 of 7 - per page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us